We demonstrate that the tetravalent S1 subunit protein COVID-19 vaccine candidate induces CD4+ and CD8+ T cell activation, as indicated by increased expression of CD69, HLA-DR, CD38, and Ki-67 activation and proliferation markers on both T cell subsets (Fig. 6). The gene discussed is CD8A; the disease is COVID-19.